OBIMFOndine Biomedical, Inc.

About Ondine Biomedical, Inc. (OBIMF)

Ondine Biomedical, Inc. (OBIMF) is a N/A company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the Pink tier.

Ondine Biomedical is a life sciences company leading the charge in breakthrough photodisinfection-based therapies to prevent and treat serious infections, including those caused by existing, emerging, and antimicrobial-resistant pathogens. Our vision is a world free from infections. We have created a patented, platform technology (photodisinfection) to provide simple solutions to complex infections across different therapeutic areas in healthcare and industry settings. We are focused on solutions that address significant needs, are easy to deploy, are environmentally safe, provide substantial public health benefits, and cost a fraction of the infections they target. Our photodisinfection technology has been used successfully for many years in more than 100,000 patient treatments in hospitals, clinics, and industrial settings across Canada.

OBIMF key facts

Ticker symbol

OBIMF

Market tier

Pink

Headquarters

Vancouver, BC, Canada

Country of incorporation

CA

Year of incorporation

1996

Employees

43

Estimated market cap

$37.74M (as of May 13, 2025)

Shares outstanding

277,285,759

Reporting standard

International Reporting: LSE - London Stock Exchange

Audit status

Not Available

Fiscal year end

12/31

Ondine Biomedical, Inc. leadership

• Carolyn Cross — CEO, Founder
• Nicolas Loebel — President, CTO
• Kwong Choo — CFO
• Alex Kaulins — Vice President
• Nikita Parkhaev — Vice President
• Simon Sinclair — CMO

Explore more: Pink stocks · OTC stocks starting with O